TIFFANIE SEETON: Open Payments
NPI 1992411888 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 22 payments from 17 companies in 2025. Trend: 2023 $59 · 2024 $1,500 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $85 |
| UCB, Inc. | 2 | $48 |
| Biogen, Inc. | 2 | $44 |
| JAZZ PHARMACEUTICALS INC. | 1 | $37 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
| Eisai Inc. | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| PFIZER INC. | 1 | $25 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $23 |
Products named: QULIPTA, LEQEMBI, UBRELVY, EPIDIOLEX, TYSABRI, INGREZZA, REXULTI, PONVORY.
Industry payments across TX — which companies pay providers there.
